pharma · Chronic Obstructive Pulmonary Disease (COPD) · Non-Small Cell Lung Cancer
AstraZeneca
AstraZeneca AB
AstraZeneca clinical programs — 79 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridgeshire CB2 0AA, GB
- Employees
- 79,242
- Programs
- 249
- Drugs
- 238
- Patents
- 2
AstraZeneca projects
79 ClinicalTrials.gov programs sponsored by AstraZeneca.
AstraZeneca has 79 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
D8530C00002
AstraZeneca AB
Estrogen Receptor Positive HER2 Negative Advanced Breast Cancer
1 trial -
D9077C00001
AstraZeneca AB
Resectable, Early-stage (II to IIIB) Non-small Cell Lung Cancer
1 trial -
D9090C00008
AstraZeneca AB
Chronic Heart Failure
1 trial -
D9102C00001
AstraZeneca AB
Stage IV Non Small Cell Lung Cancer whose tumors lack EGFR mutations and ALK fusions
1 trial -
D9106C00002
AstraZeneca AB
Non-small Cell Lung Cancer (NSCLC)
1 trial -
D9181C00002
AstraZeneca AB
Asthma
1 trial -
D933LC00001
AstraZeneca AB
First-line (1L) Stage IV Triple Negative Breast Cancer (TNBC) - the subtype of breast cancer characterized by a lack of tumor expression of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2.
1 trial -
D9520C00001
AstraZeneca AB
Metastatic Prostate Cancer
1 trial -
D9571C00001
AstraZeneca AB
Relapsed/Refractory Classical Hodgkin Lymphoma
1 trial -
D967LC00001
AstraZeneca AB
Patients with Human Epidermal Growth Factor Receptor 2 (HER2)-expressing gastric, GEJ and esophageal cancer
1 trial -
D9690C00006
AstraZeneca AB
Crohn’s Disease and an Ileostomy
1 trial -
D9720C00001
AstraZeneca AB
Advanced Solid Tumors
1 trial -
D9720C00003
AstraZeneca AB
Metastatic Prostate Cancer
1 trial -
D9804C00001
AstraZeneca AB
Locally Advanced Resectable Gastroesophageal Adenocarcinoma
1 trial -
DESTINY-Breast07
AstraZeneca AB
HER2-positive Metastatic Breast Cancer
1 trial -
DS-8201a
AstraZeneca AB
Treatment of unresectable and/or metastatic solid tumors harboring specific HER2 activating mutations regardless of tumor histology
1 trial -
DS-8201a
AstraZeneca AB
HER2 Expressing Tumors
1 trial -
Datopotamab deruxtecan
AstraZeneca AB
Locally Advanced Inoperable or Metastatic Breast Cancer Refractory to Endocrine Therapy
1 trial -
IMFINZI 50 mg/mL concentrate for solution for infusion.
AstraZeneca AB
Patients With Muscle-Invasive Bladder Cancer
1 trial -
IMFINZI 50 mg/mL concentrate for solution for infusion.
AstraZeneca AB
Locally Advanced or Metastatic Non-Small Cell Lung Cancer (Stage IIIBIV)
1 trial -
OlympiaN
AstraZeneca AB
BRCA Mutations and Early Stage HER2-Negative Breast Cancer
1 trial -
PURSUIT
AstraZeneca AB
Dyslipidemia Dyslipidemias are alterations to the plasma lipid profile associated often with clinical condition. A common form of dyslipidemia is Hypercholesterolemia due to high level of LDL-cholesterol, which is a major risk factor for Cardiovascular Disease (CVD), such as Ischemic Heart Disease and Ischemic Stroke. CVD is a leading cause of global mortality and a contributor to disability.
1 trial -
Placebo for AZD4144, AZD4144
AstraZeneca AB
Sepsis-associated acute kidney injury (AKI)
1 trial -
Placebo for AZD5148, AZD5148
AstraZeneca AB
Recurrence of Clostridioides difficile Infection
1 trial -
Rilvegostomig, Rilvegostomig
AstraZeneca AB
Advanced Non-small Cell Lung Cancer, Metastatic Non-small Cell Lung Cancer, stage III unresectable Non-small Cell Lung Cancer (Protocol Parts A-B), stage IV Non-small Cell Lung Cancer (Protocol Parts A-E).
1 trial -
SAVANNAH
AstraZeneca AB
EGFRm+ and MET+, Locally Advanced or Metastatic Non Small Cell Lung Cancer.
1 trial -
SAVANNAH/D5084C0007
AstraZeneca AB
EGFRm+ and MET+, Locally Advanced or Metastatic Non Small Cell Lung Cancer
1 trial -
SPRINKLE D1346C00004
AstraZeneca AB
Neurofibromatosis Type 1 (NF1) Related Plexiform Neurofibromas (PN)
1 trial -
Saruparib
AstraZeneca AB
Advanced/Recurrent Ovarian cancer
1 trial -
ZEAL-UNLOCK
AstraZeneca AB
Cirrhosis of the liver is a condition in which the liver is scarred and damaged
1 trial -
D798VC00001
AstraZeneca AB
Colorectal cancer
1 trial
Frequently asked questions
How many clinical projects does AstraZeneca have?
79 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.